AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount program with a lawsuit that challenges the definition of what it means to be a ...
A federal judge handed down a decision this week in a lawsuit involving the 340B prescription drug discount program as hospitals, physicians, and drug manufacturers continue to battle over how the ...
(The Center Square) – Hospitals and clinics in Michigan participating in a federal drug discount program are marking up medications and shifting costs onto public employee health plans, according to a ...
Forbes contributors publish independent expert analyses and insights. Anthony T. Lo Sasso is Professor of Public Affairs at UW-Madison This voice experience is generated by AI. Learn more. This voice ...
At a time when healthcare executives are being asked to stretch scarce federal resources as far as possible, the 340B Drug Pricing Program is a much-appreciated lifeline. Despite the program being ...
On March 17, 2026, the Ninth Circuit issued a unanimous decision in United States ex rel. Adventist Health Sys. of W. v. AbbVie Inc. allowing a large health system to pursue a False Claims Act (FCA) ...
The 340B program allows certain nonprofit hospitals to buy prescription drugs at a significant discount. Larger urban hospitals generate most of the 340B revenue, while smaller rural clinics struggle ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results